Bifidobacterium breveBifidobacterium breve
probiotic_strain
Bifidobacterium breve
Bifidobacterium breve
别名: B. breve, Yakult, M-16V, BR03
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dbifidobacterium\u002Dbreve';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
About
短双歧杆菌是婴儿肠道最早的定植菌之一，在新生儿肠道健康中起关键作用。它产生具有抗炎特性的共轭亚油酸，可能有助于从肠道内膜竞争性排除病原体。研究表明它可能支持肠屏障功能，尤其是在发育中的肠道。
How It Works
Produces conjugated linoleic acid (CLA) with anti-inflammatory effects on intestinal mucosa; competitively excludes pathogens from epithelial binding sites; modulates intestinal permeability in neonates by enhancing tight junction protein expression; ferments human milk oligosaccharides promoting infant gut colonization.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| Irritable Bowel Syndrome (IBS) | D | 2 | 150 | 查看 → |
Side Effects
- Mild gas during initial use
- Occasional loose stools in infants (transient)
- Rare abdominal discomfort
- Very rare: bacteremia in immunocompromised individuals
Drug & Supplement Interactions
- Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
- Immunosuppressants (use with caution in immunocompromised patients)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。